These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


693 related items for PubMed ID: 1829651

  • 21. Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysis.
    Goedegebuure PS, Braakman E, Segal DM, Vreugdenhil RJ, Bolhuis RL.
    Int Immunol; 1990; 2(12):1213-20. PubMed ID: 1982501
    [Abstract] [Full Text] [Related]

  • 22. Functional properties of a unique subset of cytotoxic CD3+ T lymphocytes that express Fc receptors for IgG (CD16/Leu-11 antigen).
    Lanier LL, Kipps TJ, Phillips JH.
    J Exp Med; 1985 Dec 01; 162(6):2089-106. PubMed ID: 2415663
    [Abstract] [Full Text] [Related]

  • 23. Clonal analysis of functionally distinct human CD4+ T cell subsets.
    Rotteveel FT, Kokkelink I, van Lier RA, Kuenen B, Meager A, Miedema F, Lucas CJ.
    J Exp Med; 1988 Nov 01; 168(5):1659-73. PubMed ID: 2903211
    [Abstract] [Full Text] [Related]

  • 24. Immunosuppression by lymphokine-activated murine killer cell line with B-lymphoblast-lytic activity in vitro.
    Ikemoto M, Suzuki H, Sugiyama E, Yamashita N, Tunru IS, Matsui S, Kobayashi M.
    Immunol Cell Biol; 1994 Oct 01; 72(5):375-82. PubMed ID: 7835981
    [Abstract] [Full Text] [Related]

  • 25. Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules.
    Chong AS, Boussy IA, Graf LH, Scuderi P.
    Cell Immunol; 1992 Oct 01; 144(1):69-79. PubMed ID: 1356634
    [Abstract] [Full Text] [Related]

  • 26. CD3/Ti gamma A: a functional gamma-receptor complex expressed on human peripheral lymphocytes.
    Faure F, Jitsukawa S, Triebel F, Hercend T.
    J Immunol; 1988 Mar 01; 140(5):1372-9. PubMed ID: 2964471
    [Abstract] [Full Text] [Related]

  • 27. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ, Tax WJ, van Krimpen BA, Vreugdenhil RJ, Ronteltap CP, Bolhuis RL.
    J Immunol; 1987 Mar 01; 138(5):1627-33. PubMed ID: 2949018
    [Abstract] [Full Text] [Related]

  • 28. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
    Aramburu J, Balboa MA, Izquierdo M, López-Botet M.
    J Immunol; 1991 Jul 15; 147(2):714-21. PubMed ID: 1830071
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Natural killer lines and clones with apparent antigen specificity.
    Suzuki N, Bianchi E, Bass H, Suzuki T, Bender J, Pardi R, Brenner CA, Larrick JW, Engleman EG.
    J Exp Med; 1990 Aug 01; 172(2):457-62. PubMed ID: 2142719
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Central role for TCR/CD3 ligation in the differentiation of CD4+ T cells toward A Th1 or Th2 functional phenotype.
    Röcken M, Müller KM, Saurat JH, Müller I, Louis JA, Cerottini JC, Hauser C.
    J Immunol; 1992 Jan 01; 148(1):47-54. PubMed ID: 1345789
    [Abstract] [Full Text] [Related]

  • 34. Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets.
    Quillet-Mary A, Cavarec L, Kermarrec N, Marchiol-Fournigault C, Gil ML, Conjeaud H, Fradelizi D.
    Int J Cancer; 1991 Feb 01; 47(3):473-9. PubMed ID: 1704356
    [Abstract] [Full Text] [Related]

  • 35. Sideways killing: the cytolysis of Fc receptor-bearing cells through bridging to cytolytic T lymphocytes by antibodies specific for the T-cell receptor-T3 complex.
    Ito M, Usuba O, Unkeless JC, Schreiber R, Celada F, Bona CA, Moran TM.
    Scand J Immunol; 1989 Jun 01; 29(6):659-69. PubMed ID: 2525807
    [Abstract] [Full Text] [Related]

  • 36. A novel surface molecule expressed by long-term cultured T and natural killer cells is involved in cell activation.
    Ferrini S, Cantoni C, Ciccone E, Biassoni R, Prigione I, Bottino C, Venzano P, Moretta L.
    Eur J Immunol; 1991 Sep 01; 21(9):1981-7. PubMed ID: 1832383
    [Abstract] [Full Text] [Related]

  • 37. CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta.
    Moretta A, Poggi A, Pende D, Tripodi G, Orengo AM, Pella N, Augugliaro R, Bottino C, Ciccone E, Moretta L.
    J Exp Med; 1991 Dec 01; 174(6):1393-8. PubMed ID: 1720808
    [Abstract] [Full Text] [Related]

  • 38. Normal hematopoietic progenitor cells and malignant lymphohematopoietic cells show different susceptibility to direct cell-mediated MHC-non-restricted lysis by T cell receptor-/CD3-, T cell receptor gamma delta+/CD3+ and T cell receptor-alpha beta+/CD3+ lymphocytes.
    Voogt PJ, Falkenburg JH, Fibbe WE, Veenhof WF, Hamilton M, Van Krimpen BA, Bolhuis RL.
    J Immunol; 1989 Mar 01; 142(5):1774-80. PubMed ID: 2521886
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Lymphokine-activated killer cell activity of CD4-CD8- TCR alpha beta + thymocytes.
    Arase H, Arase-Fukushi N, Good RA, Onoé K.
    J Immunol; 1993 Jul 15; 151(2):546-55. PubMed ID: 8335898
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 35.